Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs SK Telecom Co. Ltd. Common Stock (SKM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs SK Telecom Co. Ltd. Common Stock — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while SK Telecom Co. Ltd. Common Stock trades at $32.3 (market cap $12.77B). The key difference: SK Telecom Co. Ltd. Common Stock is far larger — about 13.1× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and SK Telecom Co. Ltd. Common Stock pays a 2.82% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and SK Telecom Co. Ltd. Common Stock for 6 Days on average.
| MRVI | SKM | |
|---|---|---|
Market Cap | $972.90M | $12.77B |
Volume | 4,325,710 | 1,991,125 |
Sector | Health | Media |
52-Week High | $9.00 | $46.00 |
52-Week Low | $2.83 | $19.68 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $1.08B | $18.85B |
Dividend Yield | — | 2.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
SKM trades at $34.42, up 2.9% today, showing strong earnings momentum with three consecutive quarterly beats. The stock faces technical headwinds with a bearish moving average signal despite oversold RSI conditions. Fundamentally, the company demonstrates robust gross margins of 87.51% but modest net income margins of 4.38%, with recent AI data center spin-offs creating potential value catalysts.
Outlook remains balanced with analyst consensus divided (42.85% Buy, 42.86% Hold) amid AI infrastructure expansion opportunities. Key risks include negative cash flow trends and competitive pressures in wireless communications. The current valuation at 24.39 P/E appears reasonable given growth initiatives, but execution on data center strategy will determine future performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About SK Telecom Co. Ltd. Common Stock
SK Telecom is a South Korean telecommunications company providing mobile, broadband, and digital services. It also develops services in areas such as AI, cloud, and data centers.
Read more on SKM →
